DK253187D0 - Kontinuerlig intravenoes infusion af adenosin til humanpatienter, en enhedsdosisform af adenosin og brug af adenosin til fabrikation af medikamenter - Google Patents

Kontinuerlig intravenoes infusion af adenosin til humanpatienter, en enhedsdosisform af adenosin og brug af adenosin til fabrikation af medikamenter

Info

Publication number: DK253187D0
Authority: DK; Denmark
Prior art keywords: adenosine; intravenous infusion; continuous intravenous; medicines; manufacture
Prior art date: 1985-09-24

Application number

DK253187A

Other languages

English (en)

Other versions

DK253187A (da

Inventor

Alf Sollevi

Original Assignee

Haessle Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-09-24

Filing date

1987-05-19

Publication date

1987-05-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25116698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK253187(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1987-05-19 Application filed by Haessle Ab filed Critical Haessle Ab

1987-05-19 Publication of DK253187A publication Critical patent/DK253187A/da

1987-05-19 Publication of DK253187D0 publication Critical patent/DK253187D0/da

Links

OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 title abstract 10
239000002126 C01EB10 - Adenosine Substances 0.000 title abstract 5
229960005305 adenosine Drugs 0.000 title abstract 5
238000001802 infusion Methods 0.000 title abstract 2
238000001990 intravenous administration Methods 0.000 title abstract 2
239000002552 dosage form Substances 0.000 title 1
239000003814 drug Substances 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
230000000903 blocking effect Effects 0.000 abstract 1
230000017531 blood circulation Effects 0.000 abstract 1
230000000747 cardiac effect Effects 0.000 abstract 1
210000004351 coronary vessel Anatomy 0.000 abstract 1
230000000004 hemodynamic effect Effects 0.000 abstract 1
230000024883 vasodilation Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

DK253187A 1985-09-24 1987-05-19 Kontinuerlig intravenoes infusion af adenosin til humanpatienter, en enhedsdosisform af adenosin og brug af adenosin til fabrikation af medikamenter DK253187D0 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US77951685A	1985-09-24	1985-09-24
PCT/SE1985/000423 WO1987001593A1 (en)	1985-09-24	1985-10-29	Continuous intravenous infusion of adenosine to human patients, a unit dosage form of adenosine and use of adenosine for the manufacture of medicaments

Publications (2)

Publication Number	Publication Date
DK253187A DK253187A (da)	1987-05-19
DK253187D0 true DK253187D0 (da)	1987-05-19

Family

ID=25116698

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK253187A DK253187D0 (da)	1985-09-24	1987-05-19	Kontinuerlig intravenoes infusion af adenosin til humanpatienter, en enhedsdosisform af adenosin og brug af adenosin til fabrikation af medikamenter

Country Status (9)

Country	Link
EP (2)	EP0506205B1 (da)
JP (1)	JP2535504B2 (da)
AT (2)	ATE176154T1 (da)
AU (1)	AU613304B2 (da)
CA (1)	CA1301652C (da)
DE (4)	DE3586993T3 (da)
DK (1)	DK253187D0 (da)
NZ (1)	NZ217592A (da)
WO (1)	WO1987001593A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0290496B2 (en) *	1986-10-06	1995-12-20	The University Of Virginia Alumni Patents Foundation	Use of an adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery
US5070877A (en) *	1988-08-11	1991-12-10	Medco Research, Inc.	Novel method of myocardial imaging
US6004945A (en) *	1990-05-10	1999-12-21	Fukunaga; Atsuo F.	Use of adenosine compounds to relieve pain
US5677290A (en) *	1990-05-10	1997-10-14	Fukunaga; Atsuo F.	Therapeutic use of adenosine compounds as surgical anesthetics
US5256398A (en) *	1990-11-08	1993-10-26	Whitby Research, Inc.	Composition for determining viability of tissue
US5681278A (en) *	1994-06-23	1997-10-28	Cormedics Corp.	Coronary vasculature treatment method
CN103260670A (zh)	2010-10-15	2013-08-21	塞托弗尔克斯股份有限公司	细胞分离灌流器及其用途
WO2013077283A1 (ja) *	2011-11-21	2013-05-30	国立大学法人大阪大学	腎動脈アブレーション用のカテーテルおよびシステム
CA2860831C (en)	2012-01-09	2024-09-10	Seastar Medical, Inc.	CARTRIDGE AND METHOD FOR INCREASING MYOCARDIAL FUNCTION

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3845205A (en) *	1970-06-04	1974-10-29	Univ Sydney	2-loweralkylthioadenosines
FR2129833B1 (da) *	1971-03-16	1974-08-02	Cerm Cent Europ Rech Mauvernay
ZA7468B (en) *	1973-01-16	1974-11-27	J Voorhees	Compositions and treatment of proliferatave skin diseases with phosphodiesterase inhibitors
DE3133925A1 (de) *	1981-08-27	1983-03-17	A. Nattermann & Cie GmbH, 5000 Köln	Arzneimittel zur behandlung von hypertonie
DE3406533A1 (de) *	1984-02-23	1985-08-29	Boehringer Mannheim Gmbh, 6800 Mannheim	Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten

1985
- 1985-10-29 EP EP92201323A patent/EP0506205B1/en not_active Expired - Lifetime
- 1985-10-29 WO PCT/SE1985/000423 patent/WO1987001593A1/en not_active Ceased
- 1985-10-29 AT AT92201323T patent/ATE176154T1/de not_active IP Right Cessation
- 1985-10-29 DE DE3586993T patent/DE3586993T3/de not_active Expired - Fee Related
- 1985-10-29 JP JP60504950A patent/JP2535504B2/ja not_active Expired - Lifetime
- 1985-10-29 AT AT85905544T patent/ATE84419T1/de not_active IP Right Cessation
- 1985-10-29 AU AU50655/85A patent/AU613304B2/en not_active Expired
- 1985-10-29 DE DE1999175044 patent/DE19975044I2/de active Active
- 1985-10-29 EP EP85905544A patent/EP0275249B2/en not_active Expired - Lifetime
- 1985-10-29 DE DE19853590855 patent/DE3590855T1/de not_active Withdrawn
- 1985-10-29 DE DE3588205T patent/DE3588205T2/de not_active Expired - Lifetime
1986
- 1986-09-16 NZ NZ217592A patent/NZ217592A/xx unknown
- 1986-09-23 CA CA000518809A patent/CA1301652C/en not_active Expired - Lifetime
1987
- 1987-05-19 DK DK253187A patent/DK253187D0/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE3586993D1 (de)	1993-02-25
DK253187A (da)	1987-05-19
EP0275249A1 (en)	1988-07-27
EP0506205B1 (en)	1999-01-27
WO1987001593A1 (en)	1987-03-26
CA1301652C (en)	1992-05-26
EP0275249B1 (en)	1993-01-13
ATE176154T1 (de)	1999-02-15
AU613304B2 (en)	1991-08-01
ATE84419T1 (de)	1993-01-15
DE3590855T1 (da)	1988-08-25
DE3588205T2 (de)	1999-06-02
JPS63501497A (ja)	1988-06-09
DE19975044I2 (de)	2006-02-02
EP0506205A1 (en)	1992-09-30
DE3586993T3 (de)	1998-03-19
AU5065585A (en)	1987-04-07
EP0275249B2 (en)	1997-12-17
NZ217592A (en)	1990-10-26
DE3588205D1 (de)	1999-03-11
DE3586993T2 (de)	1993-04-29
JP2535504B2 (ja)	1996-09-18

Similar Documents

Publication	Publication Date	Title
IT8203369A0 (it)	1982-03-16	Elettrostimolatore cardiaco impiantabile,di tipo fisiologico, in cui la frequenza di stimolazione e'regolata dalla frequenza respiratoria del paziente
DE60238142D1 (de)	2010-12-09	Implantierbares system
De Swiet et al.	1976	Blood pressure survey in a population of newborn infants.
DE68910159D1 (de)	1993-12-02	Dosierform für Verabreichung in der Humanmedizin.
NO167203C (no)	1991-10-16	Analogifremgangsmaate for fremstilling av terapeutisk aktive piperazinyl-derivater av puriner.
FI920956A0 (fi)	1992-03-04	Doseringsform foer administrering av oral hypoglykemisk glipisid.
KR900701308A (ko)	1990-12-01	감마-인터페론을 이용한 혈관 협착증의 치료방법
SE8506029D0 (sv)	1985-12-19	Hjert-lungsystem avsett for syresettning av en patients blod
DK253187A (da)	1987-05-19	Kontinuerlig intravenoes infusion af adenosin til humanpatienter, en enhedsdosisform af adenosin og brug af adenosin til fabrikation af medikamenter
Wechsler et al.	1986	Myocardial protection
Thomas et al.	1975	Circulatory, psychological & performance variables during 100 hours of paced continuous exercise under conditions of controlled energy intake & work output.
Davis et al.	1969	Comparison of changes in blood volume and opacity in dog digital pad and tongue.
Hultgren et al.	1952	Clinical and experimental study of use of khellin in treatment of angina pectoris
Barranco et al.	1977	Treatment of anxiety with oral hydroxyzine: an overview.
Claude et al.	1979	Applications of totally implantable telemetry systems to chronic medical research
Strömblad	1959	Effect of intra-arterially administered nicotine on the blood flow in the hand
ATE84418T1 (de)	1993-01-15	2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.
Peterson	1984	Headache. Modern concepts of diagnosis and management
Lochner	1975	Present Basis of Coronary Therapy
Mason	1975	The psychotropic drug summary.
IT8412421A1 (it)	1985-08-07	Elettrostimolatore cardiaco impiantabile, di tipo fisiologico, in cui le frequenza di stimolazione controllata dalla media della velocità di deformazione del torace causata dalla respirazione del paziente
Tiu et al.	1972	Anti-Arrhythmic and Inotropic Action of Lb-46 With Paired Pacing
Montgomery	1983	Advances with antidepressants: Clinical experiences with mianserin.
Steiner et al.	1969	The effect of glucagon on atrioventricular conduction and ventricular automaticity
Lazar	1988	Logomedicine: A doctor-patient partnership.

Legal Events

Date	Code	Title	Description
2003-10-27	AHS	Application shelved for other reasons than non-payment